Conclusions Early blockade of the renin-angiotensin system in patients with type 1 diabetes did not slow nephropathy progression but slowed the progression of retinopathy.
研究结论：对1型糖尿病患者早期应用肾素血管紧张素抑制剂并不能缓解糖尿病肾病的进展但可以减缓视网膜病变。
Method: Case control study was used to observe the changes of serum lipid levels in type 2 diabetes patients and type 2 diabetic nephropathy patients with hypertension or normotension.
方法：采用病例对照研究的方法观察2型糖尿病、2型糖尿病肾病合并高血压和不合并高血压患者血脂水平的变化。
Conclusion:Allele T of AGT gene M235T, the longer diabetes duration and history of hypertension were associated with higher risk of nephropathy in type 2 diabetic patients.
结论：AGT基因235T等位基因、糖尿病病程长、既往高血压史均可增加2型糖尿病患者合并肾病的危险；
Objective: To observe the clinical efficacy of insulin glargine, acarbose and benazepril in the combined treatment of early-stage diabetic nephropathy(DN) in type 2 diabetes mellitus(T2DM).
目的：观察甘精胰岛素、阿卡波糖与盐酸贝那普利联合治疗2型糖尿病早期肾病的临床疗效。
Conclusion the more than 6 points blood glucose test and control will delay the onset and development of complication as diabetic nephropathy in type 2 diabetes.
结论：多时段血糖控制可延缓2型糖尿病肾病的发生并对肾病有改善作用。
Conclusion the more than 6 points blood glucose test and control will delay the onset and development of complication as diabetic nephropathy in type 2 diabetes.
结论：多时段血糖控制可延缓2型糖尿病肾病的发生并对肾病有改善作用。
应用推荐